Ralph Fritsch

3.6k total citations
67 papers, 1.8k citations indexed

About

Ralph Fritsch is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Ralph Fritsch has authored 67 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Oncology, 25 papers in Molecular Biology and 22 papers in Cancer Research. Recurrent topics in Ralph Fritsch's work include Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (15 papers) and Colorectal Cancer Treatments and Studies (11 papers). Ralph Fritsch is often cited by papers focused on Pancreatic and Hepatic Oncology Research (16 papers), Cancer Genomics and Diagnostics (15 papers) and Colorectal Cancer Treatments and Studies (11 papers). Ralph Fritsch collaborates with scholars based in Germany, Switzerland and United States. Ralph Fritsch's co-authors include Dieter Saur, Roland M. Schmid, Julian Downward, Gordon Stamp, Günter Schneider, Pierre–Alain Clavien, Henrik Petrowsky, Markus E. Diefenbacher, Madhu Kumar and Matthias Gückenberger and has published in prestigious journals such as Cell, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Ralph Fritsch

64 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ralph Fritsch Germany 23 903 678 429 292 285 67 1.8k
Charles D. Lopez United States 23 987 1.1× 1.0k 1.5× 375 0.9× 223 0.8× 174 0.6× 97 1.8k
Ann Marie Egloff United States 29 1.2k 1.3× 837 1.2× 371 0.9× 430 1.5× 320 1.1× 63 2.3k
Margret Rave‐Fränk Germany 25 732 0.8× 665 1.0× 343 0.8× 395 1.4× 346 1.2× 89 1.9k
Omar M. Rashid United States 25 786 0.9× 738 1.1× 450 1.0× 415 1.4× 241 0.8× 68 1.7k
Viktória László Hungary 29 834 0.9× 715 1.1× 372 0.9× 581 2.0× 273 1.0× 70 2.3k
Marianna Kruithof‐de Julio Switzerland 25 1.2k 1.3× 651 1.0× 456 1.1× 647 2.2× 343 1.2× 76 2.2k
Dayong Zheng China 19 835 0.9× 476 0.7× 517 1.2× 331 1.1× 149 0.5× 62 1.5k
Stephan Singer Germany 28 1.2k 1.3× 458 0.7× 468 1.1× 201 0.7× 325 1.1× 76 2.1k
Kristian Unger Germany 31 1.6k 1.7× 667 1.0× 935 2.2× 446 1.5× 265 0.9× 101 2.9k
Qing Chen China 23 639 0.7× 525 0.8× 483 1.1× 191 0.7× 414 1.5× 58 1.5k

Countries citing papers authored by Ralph Fritsch

Since Specialization
Citations

This map shows the geographic impact of Ralph Fritsch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ralph Fritsch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ralph Fritsch more than expected).

Fields of papers citing papers by Ralph Fritsch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ralph Fritsch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ralph Fritsch. The network helps show where Ralph Fritsch may publish in the future.

Co-authorship network of co-authors of Ralph Fritsch

This figure shows the co-authorship network connecting the top 25 collaborators of Ralph Fritsch. A scholar is included among the top collaborators of Ralph Fritsch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ralph Fritsch. Ralph Fritsch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Schneider, Marcel, Ralph Fritsch, Daniel Pohl, et al.. (2024). Detection rate of colorectal cancer by routine colonoscopy is comparable in patients aged 45–49 and 50–54 years. Swiss Medical Weekly. 154(7). 3769–3769.
3.
Stintzing, Sebastian, Jan Wierecky, Axel Wein, et al.. (2024). Encorafenib plus cetuximab in patients with metastatic, BRAF V600E-mutated, colorectal carcinoma: First effectiveness data of the European multi-centric, multi-national, non-interventional study—BERING-CRC.. Journal of Clinical Oncology. 42(16_suppl). 3551–3551. 1 indexed citations
4.
5.
Stintzing, Sebastian, Jan Wierecky, Helmut Forstbauer, et al.. (2023). Disease characteristics and clinical practice of BRAF V600E-mutant metastatic colorectal cancer treatment: Baseline analysis of patients enrolled in the BERING CRC study.. Journal of Clinical Oncology. 41(4_suppl). 34–34. 1 indexed citations
6.
Pavone, Giuliana, Daniel Helbling, Saskia Hussung, et al.. (2023). Is Computed-Tomography-Based Body Composition a Reliable Predictor of Chemotherapy-Related Toxicity in Pancreatic Cancer Patients?. Cancers. 15(17). 4398–4398. 1 indexed citations
7.
8.
Akhoundova, Dilara, Martina Haberecker, Ralph Fritsch, et al.. (2022). Targeting ALK in Neuroendocrine Tumors of the Lung. Frontiers in Oncology. 12. 911294–911294. 16 indexed citations
9.
Schmid, Severin, Heiko Becker, Ralph Fritsch, et al.. (2022). Study Protocol for a Randomised Controlled Trial on Pulmonary Metastasectomy vs. Standard of Care in Colorectal Cancer Patients With ≥ 3 Lung Metastases (PUCC-Trial). Frontiers in Oncology. 12. 913896–913896. 5 indexed citations
10.
Dosso, Sara De, Alexander Siebenhüner, Thomas Winder, et al.. (2021). Treatment landscape of metastatic pancreatic cancer. Cancer Treatment Reviews. 96. 102180–102180. 120 indexed citations
11.
Hancock, David C., Sareena Rana, Philip East, et al.. (2019). RAC1P29S Induces a Mesenchymal Phenotypic Switch via Serum Response Factor to Promote Melanoma Development and Therapy Resistance. Cancer Cell. 36(1). 68–83.e9. 90 indexed citations
12.
Gkika, Eleni, Iosif Strouthos, Simon Kirste, et al.. (2018). Repeated SBRT for in- and out-of-field recurrences in the liver. Strahlentherapie und Onkologie. 195(3). 246–253. 16 indexed citations
13.
Gkika, Eleni, Simon Kirste, Sonja Adebahr, et al.. (2017). Stereotactic body radiotherapy (SBRT) for locally advanced intrahepatic and extrahepatic cholangiocarcinoma. BMC Cancer. 17(1). 781–781. 32 indexed citations
14.
Kulemann, Birte, Sylvia Timme, Peter Bronsert, et al.. (2017). Pancreatic cancer: Circulating Tumor Cells and Primary Tumors show Heterogeneous KRAS Mutations. Scientific Reports. 7(1). 4510–4510. 67 indexed citations
15.
16.
Fritsch, Ralph & Julian Downward. (2013). SnapShot: Class I PI3K Isoform Signaling. Cell. 154(4). 940–940.e1. 34 indexed citations
17.
18.
Fritsch, Ralph, et al.. (2007). HMGA1 Controls Transcription of Insulin Receptor to Regulate Cyclin D1 Translation in Pancreatic Cancer Cells. Cancer Research. 67(10). 4679–4686. 34 indexed citations
19.
Schneider, Günter, Maximilian Reichert, Dieter Saur, et al.. (2007). HDAC3 is linked to cell cycle machinery in MiaPaCa2 cells by regulating transcription of skp2. Cell Proliferation. 40(4). 522–531. 8 indexed citations
20.
Geisler, Fabian, Martin Storr, Ralph Fritsch, et al.. (2002). Endoscopic treatment of a Zenker’s diverticulum using argon plasma coagulation in a patient with massive cachexia and esophageal obstruction: a case report and review of literature. Diseases of the Esophagus. 15(2). 180–185. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles D. Lopez Breakdown of academic impact, for papers by Ann Marie Egloff Breakdown of academic impact, for papers by Margret Rave‐Fränk Breakdown of academic impact, for papers by Omar M. Rashid Breakdown of academic impact, for papers by Viktória László Breakdown of academic impact, for papers by Marianna Kruithof‐de Julio Breakdown of academic impact, for papers by Dayong Zheng Breakdown of academic impact, for papers by Stephan Singer Breakdown of academic impact, for papers by Kristian Unger Breakdown of academic impact, for papers by Qing Chen
Rankless by CCL
2026